Biocon Initiates Talks for Potential Stake Sale in Biosimilar Arm & Syngene | ET Now Exclusive ET NOW 1:52 1 year ago 1 676 Далее Скачать
Looking At Growing The Biosimilar Biz In North America & Canada: Biocon Biologics | CNBC TV18 CNBC-TV18 7:59 1 year ago 1 185 Далее Скачать
Remain Firm & Committed On The FY19 Target Of $250 M Target From Biosimilars: Biocon CNBC-TV18 2:54 7 years ago 86 Далее Скачать
Biocon Biologics: Revolutionizing Healthcare with Biosimilars Biocon Biologics 1:02 1 year ago 242 Далее Скачать
'Serum Keen To Have Stake In Biocon Biologics,' Kiran Mazumdar-Shaw On ET Now ET NOW 6:56 1 year ago 409 Далее Скачать
Biocon Biologics is well-placed to take advantage of opportunities in the biosimilars space: CEO CNBC International Live 2:08 1 year ago 864 Далее Скачать
Impact Silver CEO Discusses Plomosas Zinc Mine and 2025 Outlook at VRIC Proactive Investors 4:27 1 day ago 83 Далее Скачать
Reporter's Take | Biocon Biologics raises Rs 530 crore at steep $3 bn valuation moneycontrol 4:15 5 years ago 752 Далее Скачать
Insulin Glargine: Journey to the historic U.S. approval for the first interchangeable biosimilar Biocon Limited 2:32 3 years ago 3 391 Далее Скачать
Biocon Launches Biosimilar Adalimumab In US Market, Drug Used For Arthritis, Skin Disorders CNBC-TV18 7:56 1 year ago 2 370 Далее Скачать
Biocon-Mylan launch Semglee: A biosimilar Insulin Glargine in the US | Kiran Majumdar Shaw to ET Now ET NOW 1:48 4 years ago 662 Далее Скачать
Research Talks - Georgina Energy #gex, Mendell Helium #mdh, Vinanz #btc StockBox 33:37 1 day ago 130 Далее Скачать
The Power of One: What happens when ideas come together to become one? Biocon Biologics 1:44 1 year ago 270 Далее Скачать
